Daniel Faga Anaptysbio, Inc (ANAB) insider trading activity

ANAB Quotes by TradingView

Daniel Faga is CEO of ANAPTYSBIO, INC. Currently has a direct ownership of 401,646 shares of ANAB, which is worth approximately $8.5 Million. The most recent transaction as insider was on Mar 26, 2024, when has been sold 347,441 shares (Common Stock) at a price of $21.6 per share, resulting in proceeds of $7,504,725. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 402K
0% 3M change
54.72% 12M change
Total Value Held $8.5 Million

Daniel Faga Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 26 2024
SELL
Payment of exercise price or tax liability
$7,504,725 $21.6 p/Share
347,441 Reduced 46.38%
401,646 Common Stock
Mar 25 2024
SELL
Open market or private sale
$64,260 $21.42 p/Share
3,000 Reduced 0.4%
749,087 Common Stock
Mar 22 2024
SELL
Open market or private sale
$3,324,513 $22.78 p/Share
145,940 Reduced 16.25%
752,087 Common Stock
Jan 08 2024
SELL
Open market or private sale
$149,747 $21.81 p/Share
6,866 Reduced 0.76%
898,027 Common Stock
Jan 06 2024
BUY
Exercise of conversion of derivative security
-
17,850 Added 1.93%
904,893 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
887,043 Added 50.0%
887,043 Common Stock

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
EVP, Chief Operating Officer
DF

Daniel Faga

CEO
San Diego, CA

Track Institutional and Insider Activities on ANAB

Follow ANAPTYSBIO, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ANAB shares.

Notify only if

Insider Trading

Get notified when an Anaptysbio, Inc insider buys or sells ANAB shares.

Notify only if

News

Receive news related to ANAPTYSBIO, INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ANAB